When the Lung Master Protocol clinical trial (Lung-MAP or S1400) (1) was launched in June 2014, the goal of this first-of-its kind trial was simple: find effective treatments for seriously ill patients suffering from a specific type of lung cancer.
How the Lung-MAP Clinical Trial is Responding to Rapidly Changing Science
Chief of Medical Oncology, associate director for translational research, Yale Cancer Center
Director, Thoracic Oncology Program, University of California, Davis
YOU MAY BE INTERESTED IN
The National Coalition for Cancer Survivorship has provided the Cancer History Project with a rich archive of its newsletters: the NCCS Networker, volumes 1-11.